Picard Medical (PMI) Liabilities and Shareholders Equity (2024 - 2026)

Picard Medical has reported Liabilities and Shareholders Equity for 3 years, with the latest figure at $11.2 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $11.2 million; the trailing twelve-month figure through Mar 2026 stood at $59.0 million (up 387.3% YoY), and the FY2025 full-year result was $22.5 million, up 86.25% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $11.2 million, down from $22.5 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $22.5 million in Q4 2025, with the low at $11.2 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $14.2 million across 3 years, with a median of $12.1 million in 2024.
• The largest YoY upside for Liabilities and Shareholders Equity was 86.25% in 2025 against a maximum downside of 86.25% in 2025.
• Picard Medical's Liabilities and Shareholders Equity stood at $12.1 million in 2024, then soared by 86.25% to $22.5 million in 2025, then slumped by 50.24% to $11.2 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $11.2 million (Q1 2026), $22.5 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.